Why Longevity Trials Struggle With Endpoints — and What Researchers Are Using Instead
The most seductive endpoint in longevity science is also the least practical one: living longer. In mice, that is manageable. […]
Are GLP-1s the First Longevity Drugs — or Just the First Big Proxy?
Few drug classes have moved from endocrinology into so many neighboring territories so quickly. What began as a diabetes story
From 9 to 12 Hallmarks: The Aging Framework That Now Shapes Longevity Science
For a field obsessed with complexity, longevity science has an unusual attachment to one simple idea: aging can be organized